Table of Contents

2019-2024 Global Gene Therapies for Cancer Treatment Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapies for Cancer Treatment Market Size 2014-2024
2.1.2 Gene Therapies for Cancer Treatment Market Size CAGR by Region
2.2 Gene Therapies for Cancer Treatment Segment by Type
2.2.1 Somatic Cell Gene Therapy (SCGT)
2.2.2 Germline Gene Therapy (GGT)
2.3 Gene Therapies for Cancer Treatment Market Size by Type
2.3.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Type (2014-2019)
2.3.2 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (2014-2019)
2.4 Gene Therapies for Cancer Treatment Segment by Application
2.4.1 Cancer Research Centers
2.4.2 Diagnostic Laboratories
2.4.3 Cancer Hospitals
2.4.4 Others
2.5 Gene Therapies for Cancer Treatment Market Size by Application
2.5.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Application (2014-2019)
2.5.2 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Gene Therapies for Cancer Treatment by Players
3.1 Global Gene Therapies for Cancer Treatment Market Size Market Share by Players
3.1.1 Global Gene Therapies for Cancer Treatment Market Size by Players (2017-2019)
3.1.2 Global Gene Therapies for Cancer Treatment Market Size Market Share by Players (2017-2019)
3.2 Global Gene Therapies for Cancer Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Gene Therapies for Cancer Treatment by Regions
4.1 Gene Therapies for Cancer Treatment Market Size by Regions
4.2 Americas Gene Therapies for Cancer Treatment Market Size Growth
4.3 APAC Gene Therapies for Cancer Treatment Market Size Growth
4.4 Europe Gene Therapies for Cancer Treatment Market Size Growth
4.5 Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth

5 Americas
5.1 Americas Gene Therapies for Cancer Treatment Market Size by Countries
5.2 Americas Gene Therapies for Cancer Treatment Market Size by Type
5.3 Americas Gene Therapies for Cancer Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Gene Therapies for Cancer Treatment Market Size by Countries
6.2 APAC Gene Therapies for Cancer Treatment Market Size by Type
6.3 APAC Gene Therapies for Cancer Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Gene Therapies for Cancer Treatment by Countries
7.2 Europe Gene Therapies for Cancer Treatment Market Size by Type
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Gene Therapies for Cancer Treatment by Countries
8.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Type
8.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Gene Therapies for Cancer Treatment Market Forecast
10.1 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024)
10.2 Global Gene Therapies for Cancer Treatment Forecast by Regions
10.2.1 Global Gene Therapies for Cancer Treatment Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Gene Therapies for Cancer Treatment Forecast by Type
10.8 Global Gene Therapies for Cancer Treatment Forecast by Application

11 Key Players Analysis
11.1 Takara Bio
11.1.1 Company Details
11.1.2 Gene Therapies for Cancer Treatment Product Offered
11.1.3 Takara Bio Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Takara Bio News
11.2 Tocagen
11.2.1 Company Details
11.2.2 Gene Therapies for Cancer Treatment Product Offered
11.2.3 Tocagen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Tocagen News
11.3 VBL Therapeutics
11.3.1 Company Details
11.3.2 Gene Therapies for Cancer Treatment Product Offered
11.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 VBL Therapeutics News
11.4 Cold Genesys
11.4.1 Company Details
11.4.2 Gene Therapies for Cancer Treatment Product Offered
11.4.3 Cold Genesys Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Cold Genesys News
11.5 Genprex
11.5.1 Company Details
11.5.2 Gene Therapies for Cancer Treatment Product Offered
11.5.3 Genprex Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Genprex News
11.6 Momotaro-Gene
11.6.1 Company Details
11.6.2 Gene Therapies for Cancer Treatment Product Offered
11.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Momotaro-Gene News
11.7 MultiVir
11.7.1 Company Details
11.7.2 Gene Therapies for Cancer Treatment Product Offered
11.7.3 MultiVir Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 MultiVir News
11.8 SynerGene Therapeutics
11.8.1 Company Details
11.8.2 Gene Therapies for Cancer Treatment Product Offered
11.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 SynerGene Therapeutics News
11.9 Ziopharm Oncology
11.9.1 Company Details
11.9.2 Gene Therapies for Cancer Treatment Product Offered
11.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Ziopharm Oncology News
11.10 Anchiano Therapeutics
11.10.1 Company Details
11.10.2 Gene Therapies for Cancer Treatment Product Offered
11.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Anchiano Therapeutics News
11.11 Celgene
11.12 Celsion
11.13 Bluebird Bio

12 Research Findings and Conclusion